. Blood flow-dependent changes in renal interstitial guanosine 3Ј,5Ј-cyclic monophosphate in rabbits. Am J Physiol Renal Physiol 282: F238-F244, 2002. First published September 21, 2001 10.1152/ajprenal. 00087.2001.-We examined responses of renal interstitial guanosine 3Ј,5Ј-cyclic monophosphate (cGMP) to changes in renal perfusion pressure (RPP) within and below the range of renal blood flow (RBF) autoregulation. A microdialysis method was used to monitor renal cortical and medullary interstitial cGMP levels in anesthetized rabbits. RPP was reduced in two steps: from ambient pressure (89 Ϯ 3 mmHg) to 70 Ϯ 2 mmHg (step 1) and then to 48 Ϯ 3 mmHg (step 2). RBF was maintained in step 1 but was significantly decreased in step 2 from 2.94 Ϯ 0.23 to 1.47 Ϯ 0.08 ml⅐min Ϫ1 ⅐g
Ϫ1. Basal interstitial concentrations of cGMP were significantly lower in the cortex than in the medulla (12.1 Ϯ 1.4 and 19.9 Ϯ 0.4 nmol/l, respectively). Cortical and medullary cGMP did not change in step 1 but were significantly decreased in step 2, with significantly less reduction in cGMP concentrations in the medulla than in the cortex (Ϫ25 Ϯ 3 and Ϫ44 Ϯ 3%, respectively). Over this pressure range, changes in cortical and medullary cGMP were highly correlated with changes in RBF (r ϭ 0.94, P Ͻ 0.005 for cortex; r ϭ 0.82, P Ͻ 0.01 for medulla). Renal interstitial nitrate/nitrite was not changed in step 1 but was significantly decreased in step 2 (Ϫ38 Ϯ 2% in cortex and Ϫ20 Ϯ 2% in medulla). Nitric oxide synthase inhibition with N G -nitro-L-arginine methyl ester (L-NAME, 30 mg/kg bolus, 50 mg⅐kg Ϫ1 ⅐h Ϫ1 iv infusion) significantly decreased RBF (by Ϫ46 Ϯ 4%) and interstitial concentrations of cGMP (Ϫ27 Ϯ 4% in cortex and Ϫ22 Ϯ 4% in medulla, respectively). During L-NAME treatment, renal interstitial concentrations of cGMP in the cortex and medulla were similarly not altered in step 1. However, L-NAME significantly attenuated cGMP responses to a reduction in RPP in step 2. These results indicate that acute changes in RBF result in alterations in nitric oxide-dependent renal interstitial cGMP levels, with differential effects in the medulla compared with the cortex. renal interstitium; nitric oxide; renal blood flow; renal perfusion pressure; microdialysis NITRIC OXIDE (NO) is synthesized locally in the kidneys and plays a critical role in regulating renal hemodynamics as well as in sodium and water reabsorption through activation of soluble guanylate cyclase, which leads to accumulation of guanosine 3Ј,5Ј-cyclic monophosphate (cGMP) (19,20,23,27,(33)(34)(35)(36). One of the important mechanisms of NO-mediated cGMP production is controlled by alteration of shear stress (1, 3, 6, 9, 22), which is influenced by the fluid flow rate, fluid viscosity, and vessel diameter (1). Studies with isolated rat perfused kidneys (6) showed that increasing perfusate viscosity dilates the renal vasculature, and this is attenuated by treatment with NO synthase (NOS) inhibition. Using isolated rabbit afferent arterioles, Juncos et al. (9) demonstrated that endoth...